Predictive and precision medicine is the future of the healthcare industry, according to key players who spoke at a top forum in Bahrain.
M42 Bahrain chief executive officer Dr Mohamed Al Saati, Pharos Capital Group founding partner, chairman and CEO Kneeland Youngblood and CEC Capital Group founding partner Irene Hong discussed the future of the industry during a panel discussion, titled ‘Healthcare Capital: Strategies for Medical Innovation’, at Gateway Gulf yesterday .
&uuid=(email))